Spring Bank Pharmaceuticals Inc. (SBPH): Investor showing Interest in it

0
32

Spring Bank Pharmaceuticals Inc. (NASDAQ:SBPH) changes shares on Tuesday trading session, with a change of -1.30% or -$0.02 shares. The trading starts at $1.52 and closed at $1.54 throughout the day. The trading session low price was $1.452 and day high was $1.54 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 0.22 million while its average volume is 249.60K. In other hand, the SBPH market cap reached to $32.56M. While, its current target price is $1.75.

On May 7, 2020, BRIEF-Spring Bank Pharmaceuticals Q1 Loss Per Share $0.49. According to the news reported on Reuters, * SPRING BANK PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL AND OPERATIONAL RESULTS

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -40.86% and down -1.30% for month. Its quarterly performance was 16.03% above, while its half year performance is up 34.39%. SBPH yearly performance stood at negative -63.20% and fall -3.80% for year-to-date. Current recommendation for Spring Bank Pharmaceuticals Inc. is 3.00.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. SBPH EPS (TTM) for 12-month is -1.64. EPS for this year is 7.90%, while for the next year its value is -0.89. Its EPS Q/Q reached -56.60%. It has an EPS of -1.30% down for past five years.

Let’s take a look on the analyst recommendations on SBPH for the current month and previous month. For the current month, 0 of 2 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 2 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $1.50 – $2.00. Average target price for SBPH was reached at $1.75.

BVF Inc., Vanguard Group, Inc. (The) and Tiedemann Advisors, LLC are the top three holders in Spring Bank Pharmaceuticals Inc. (SBPH) stock. On Mar 30, 2020, BVF Inc. has 0.95 million shares which valued 0.89 million. On Mar 30, 2020, Vanguard Group, Inc. (The) owned 0.45 million shares which valued at 0.42 million. On Mar 30, 2020, Tiedemann Advisors, LLC has a total of 0.36 million shares which valued at 0.34 million. In the end, Tiedemann Advisors, LLC have 2.12% shares outstanding of Spring Bank Pharmaceuticals Inc. (SBPH) on Mar 30, 2020. The insider ownership moved to 0.60% and institutional holding shifted to 27.90%.

The company posted an EPS (TTM) of -1.64. According to the most recent quarter report on (Jun 2020), 1 analysts estimated an average EPS of -0.36, while -0.28 EPS posted a year ago period. Analyst Estimated EPS for SBPH published in the report was -$0.36 – -$0.36 during the same period. Comparing with last year, the average estimated EPS was -0.28 which is higher than -0.49 which was posted for recent quarter EPS.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for SBPH fall -18.98% for period of 200 days. SMA for 50 days was -8.18% which is showing red signal, while SMA-20 was -10.77%. The moving average value for Spring Bank Pharmaceuticals Inc. (SBPH) is 71.12k and 0.35% for 200 and 50 days respectively.

Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in SBPH stock. On Dec 30, Eichler Kurt M, Director, sold 40,000 trading shares at the cost of $1.26, which valued at 50540.0. On Nov 14, Freve Jonathan, CFO & Treasurer, bought 5,000 shares at the cost of $3.04, with total shares of 17,482. On Nov 13, Driscoll Martin J, President and CEO, bought 5,000 shares at the cost of 2.83. After this transaction, Driscoll Martin J total shares reached to 90,400 which valued at 14150.0.